David Rescott

Stock Analyst at Baird

(3.38)
# 764
Out of 5,182 analysts
84
Total ratings
54.69%
Success rate
2.53%
Average return

Stocks Rated by David Rescott

Edwards Lifesciences
Apr 24, 2026
Maintains: Neutral
Price Target: $85$87
Current: $83.33
Upside: +4.40%
Boston Scientific
Apr 23, 2026
Maintains: Outperform
Price Target: $86$78
Current: $56.85
Upside: +37.20%
Intuitive Surgical
Apr 22, 2026
Maintains: Outperform
Price Target: $575$610
Current: $452.35
Upside: +34.85%
PROCEPT BioRobotics
Mar 6, 2026
Initiates: Neutral
Price Target: $30
Current: $24.83
Upside: +20.82%
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $103$100
Current: $78.30
Upside: +27.71%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $345$374
Current: $324.65
Upside: +15.20%
SI-BONE
Dec 18, 2025
Maintains: Buy
Price Target: $21$23
Current: $13.35
Upside: +72.28%
Haemonetics
Dec 15, 2025
Maintains: Outperform
Price Target: $87$99
Current: $55.32
Upside: +78.96%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $63$70
Current: $59.07
Upside: +18.50%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $62.01
Upside: +77.39%